Research focuses on the economic impact of tobacco on health and healthcare expenditures. Dr. Max and her colleagues have worked for over two decades to develop models to estimate the costs associated with smoking and exposure to secondhand smoke.
An important component of any FDA regulation of tobacco products is an economic analysis of the regulation. Models of the health-related economic costs of cigarette smoking have evolved and improved over the years, and current models take into account the complex relationship between smoking, health, and healthcare expenditures. However, there is a lack of research on healthcare costs attributable to the use of tobacco products other than cigarettes. It is important to have this information given the increased rates at which non-cigarette products are being used.
Stanford University, 1976, BA, History, Economics University of Colorado, 1981, MA, Economics University of Colorado, 1983, Ph.D., Economics